The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosis.
acute‐on‐chronic liver failure
survival
transjugular intrahepatic portosystemic shunt
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
revised:
14
08
2024
received:
06
06
2024
accepted:
25
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
9
9
2024
Statut:
aheadofprint
Résumé
The recently developed Freiburg Index of Post-TIPS Survival (FIPS) allows improved risk classification of patients with decompensated cirrhosis allocated to transjugular intrahepatic portosystemic shunt (TIPS) implantation. This study investigated the prognostic value of the FIPS in patients hospitalized with acute decompensation of cirrhosis (AD), outside the setting of TIPS implantation. A total of 1133 patients with AD were included in a retrospective, multi-centre study. Ninety-day, 180-day and 1-year mortality were recorded and the FIPS' performance in predicting mortality at these time points was analysed using ROC analyses. Ninety-day, 180-day and 1-year mortality were 17.7%, 24.4% and 30.8%. Uni- and multivariable Cox regression models showed that the FIPS independently predicted 1-year mortality in the study cohort (HR 1.806, 95% CI 1.632-1.998, p < .0001). In ROC analyses, the FIPS offered consistently high performance in the prediction of mortality within 1 year after AD (area under the receiver operator characteristic [AUROC]: 1-year mortality .712 [.679-.746], 180-day mortality .740 [.705-.775] and 90-day mortality .761 [.721-.801]). In fact, in the subgroup of patients presenting with variceal bleeding, the FIPS even showed significantly improved discriminatory performance in the prediction of long-term mortality (AUROC 1-year mortality: .782 [.724-.839]) in comparison with established prognostic scores, such as the CLIF-C AD score (.724 [.660-.788], p = .0071) or MELD 3.0 (.726 [.662-.790], p = .0042). The FIPS accurately predicts mortality in patients with AD and seems to offer superior prognostication of long-term mortality in patients with variceal bleeding.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Liver International published by John Wiley & Sons Ltd.
Références
D'Amico G, Garcia‐Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217‐231. doi:10.1016/j.jhep.2005.10.013
Moreau R, Jalan R, Gines P, et al. Acute‐on‐chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426‐1437.e9. doi:10.1053/j.gastro.2013.02.042
Pugh RN, Murray‐Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646‐649. doi:10.1002/bjs.1800600817
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864‐871. doi:10.1053/he.2000.5852
Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver‐transplant waiting list. N Engl J Med. 2008;359:1018‐1026. doi:10.1056/NEJMoa0801209
Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the model for end‐stage liver disease updated for the modern era. Gastroenterology. 2021;161:1887‐1895.e4. doi:10.1053/j.gastro.2021.08.050
Jalan R, Pavesi M, Saliba F, et al. The CLIF consortium acute decompensation score (CLIF‐C ADs) for prognosis of hospitalised cirrhotic patients without acute‐on‐chronic liver failure. J Hepatol. 2015;62:831‐840. doi:10.1016/j.jhep.2014.11.012
Gülcicegi DE, Goeser T, Kasper P. Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives. Front Med. 2023;10:1268102.
Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post‐TIPS survival. J Hepatol. 2021;74:1362‐1372. doi:10.1016/j.jhep.2021.01.023
Stockhoff L, Schneider H, Tergast TL, Cornberg M, Maasoumy B. Freiburg index of post‐TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS? J Hepatol. 2021;75:487‐489. doi:10.1016/j.jhep.2021.02.031
Angeli P, Bernardi M, Villanueva C, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406‐460. doi:10.1016/j.jhep.2018.03.024
Vandenbroucke JP, Von EE, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297. doi:10.1371/journal.pmed.0040297
Jalan R, Pavesi M, Saliba F, et al. Erratum to “the CLIF consortium acute decompensation score (CLIF‐C ADs) for prognosis of hospitalised cirrhotic patients without acute‐on‐chronic liver failure”. J Hepatol. 2015;63:291. doi:10.1016/j.jhep.2015.04.002
DeLong ER, DeLong DM, Clarke‐Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837‐845.
Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73:842‐854. doi:10.1016/j.jhep.2020.06.013